EPISODE · Sep 13, 2022 · 9 MIN
What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections?
from The Morning Show with Devon Peacock · host Corus Radio
On April 14, 2022, Health Canada approved AstraZeneca’s antibody combination, known as Evusheld, to prevent symptomatic COVID-19 infection in immunocompromised people. Infectious disease expert Dr. Isaac Bogoch joins Devon Peacock to discuss.
NOW PLAYING
What is Evusheld and how can it help immunocompromised people avoid symptomatic COVID-19 infections?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m